@kdjhaveri
Kenar Jhaveri
@kdjhaveri
4 years
The STARMEN trial is out!!! indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy. @Kidney_Int
Tweet card media
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is...

A cyclical corticosteroid-cyclophosphamide regimen is recommended for patients with primary membranous nephropathy at high risk of progression. We hypothesized that sequential therapy with tacrolimus...

www.kidney-international.org
3
31
80

Replies

@OrhanEfe_
Orhan Efe
@OrhanEfe_
4 years
@kdjhaveri @Kidney_Int Thanks for sharing. Why was only one dose rituximab given?
1
0
3
@PepaSolerR
Maria Jose Soler
@PepaSolerR
4 years
@kdjhaveri @Kidney_Int Thanks to @Gmfernandez6 and Manuel Praga. @ERAEDTA
0
0
1
@nephondemand
Tejas Desai, MD, MBA
@nephondemand
4 years
@kdjhaveri @docarshadali @Kidney_Int Here is the question and answer session from Kidney Week 2020 about STARMEN
Tweet card media
starmen
null
www.youtube.com
1
3
7